HUTCHMED (China) Limited ADR (HCM)

전일 마감가:

$19.45

열려 있는:

$19.2

하루 거래량:

76,857

시가총액:

$3.32B

수익:

$838.00M

순이익/손실:

$100.78M

주가수익비율:

-77.88

EPS:

-0.25

순현금흐름:

$186.65M

1주 성능:

+3.78%

1개월 성능:

+15.41%

6개월 성능:

-0.15%

1년 성능:

+25.45%

1일 변동 폭

$19.19

$19.51

52주 변동 폭

$10.68

$20.73

HUTCHMED (China) Limited ADR Stock (HCM) Company Profile

명칭

HUTCHMED (China) Limited ADR

부문

Healthcare (1215)

산업

Drug Manufacturers - Specialty & Generic (3)

전화

852 2121 8200

주소

Hutchison House, 22nd Floor 10 Harcourt Road, Central

직원

590

트위터

@hchimed

다음 수익 날짜

2024-06-05

최신 SEC 제출 서류

HCM's Discussions on Twitter

HUTCHMED (China) Limited ADR Stock (HCM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-11-24	업그레이드	Deutsche Bank	Hold → Buy
2022-05-04	다운그레이드	Deutsche Bank	Buy → Hold
2021-09-22	다운그레이드	Goldman	Buy → Neutral
2021-08-03	개시	Jefferies	Buy
2020-10-02	개시	Deutsche Bank	Buy
2020-03-13	개시	Cantor Fitzgerald	Overweight
2020-02-20	개시	Goldman	Buy
2019-11-19	개시	CLSA	Buy
2019-10-23	재확인	BofA/Merrill	Buy
2019-07-05	개시	Macquarie	Outperform

모두보기

HUTCHMED (China) Limited ADR 주식(HCM)의 최신 뉴스

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

GlobeNewswire Inc.

HUTCHMED (HCM) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research

Does HUTCHMED (HCM) Have the Potential to Rally 38.13% as Wall Street Analysts Expect?

Zacks Investment Research

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

GlobeNewswire Inc.

HUTCHMED Highlights Data to be Presented at AACR Congress 2024

GlobeNewswire Inc.

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status

GlobeNewswire Inc.

HUTCHMED (China) Limited ADR (HCM) 재무 분석

HUTCHMED (China) Limited ADR (HCM) 매출 2024

HUTCHMED (China) Limited ADR (HCM) 순이익 2024

HUTCHMED (China) Limited ADR (HCM) 현금흐름 2024

HUTCHMED (China) Limited ADR (HCM) 주당 순이익 2024